Polyamidomine dendrimers: An excellent drug carrier for improving the solubility and bioavailability of puerarin

Pharmaceutical Development and Technology

Volumn 18, Issue 5, 2013, Pages 1051-1057

  Gu, Lin ^a   Wu, Zheng Hong ^a   Qi, Xiaole ^a   He, Huan ^a   Ma, Xiaoli ^a   Chou, Xiaohua ^a   Wen, Xiaoguang ^b   Zhang, Miao ^b   Jiao, Fang ^b  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b Yangtze River Pharmaceutical Group   (China)

Author keywords

PAMAM; Pharmacokinetics; Polyamidoamine dendrimers; Puerarin; Puerarin PAMAM complex; Solubility

Indexed keywords

DENDRIMER; DRUG CARRIER; POLYAMIDOAMINE; PUERARIN;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BLOOD TOXICITY; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG SOLUBILITY; HEMOLYSIS; IN VITRO STUDY; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PH; PRIORITY JOURNAL; RAT; SUSPENSION; TIME TO MAXIMUM PLASMA CONCENTRATION;

ANIMALS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; DENDRIMERS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; ERYTHROCYTES; HEMOLYSIS; HYDROGEN-ION CONCENTRATION; ISOFLAVONES; MALE; PHARMACEUTICAL SOLUTIONS; RATS; RATS, SPRAGUE-DAWLEY; SOLUBILITY; SUSPENSIONS;

EID: 84886076491     PISSN: 10837450     EISSN: 10979867     Source Type: Journal    
DOI: 10.3109/10837450.2011.653822     Document Type: Article

References (39)

1. Kulhari H, Pooja D, Prajapati SK, Chauhan AS. Performance evaluation of PAMAM dendrimer based simvastatin formulations. Int J Pharm 2011;405:203-209.
2. Baker JR Jr. Dendrimer-based nanoparticles for cancer therapy. Hematology Am Soc Hematol Educ Program 2009;708-719.
3. Duncan R. Polymer conjugates as anticancer nanomedicines. Nat Rev Cancer 2006;6:688-701.
4. Talanov VS, Regino CA, Kobayashi H, Bernardo M, Choyke PL, Brechbiel MW. Dendrimer-based nanoprobe for dual modality magnetic resonance and fuorescence imaging. Nano Lett 2006;6:1459-1463.
5. Yoon HC, Hong MY, Kim HS. Afnity biosensor for avidin using a double functionalized dendrimer monolayer on a gold electrode. Anal Biochem 2000;282:121-128.
6. Han HJ, Kannan RM, Wang S, Mao G, Kusanovic JP, Romero R. Multifunctional dendrimer-templated antibody presentation on biosensor surfaces for improved biomarker detection. Adv Funct Mater 2010;20:409-421.
7. Lin Y, Fujimori T, Kawaguchi N, Tsujimoto Y, Nishimi M, Dong Z et al. Polyamidoamine dendrimers as novel potential absorption enhancers for improving the small intestinal absorption of poorly absorbable drugs in rats. J Control Release 2011;149:21-28.
8. Cheng Y, Xu T. The effect of dendrimers on the pharmacodynamic and pharmacokinetic behaviors of non-covalently or covalently attached drugs. Eur J Med Chem 2008;43:2291-2297.
9. Cheng Y, Xu Z, Ma M, Xu T. Dendrimers as drug carriers: applications in diferent routes of drug administration. J Pharm Sci 2008;97:123-143.
10. Patri AK, Kukowska-Latallo JF, Baker JR Jr. Targeted drug delivery with dendrimers: comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex. Adv Drug Deliv Rev 2005;57:2203-2214.
11. Svenson S. Dendrimers as versatile platform in drug delivery applications. Eur J Pharm Biopharm 2009;71:445-462.
12. Kitchens KM, Kolhatkar RB, Swaan PW, Ghandehari H. Endocytosis inhibitors prevent poly(amidoamine) dendrimer internalization and permeability across Caco-2 cells. Mol Pharm 2008;5:364-369.
13. Dong Z, Katsumi H, Sakane T, Yamamoto A. Effects of polyamidoamine (PAMAM) dendrimers on the nasal absorption of poorly absorbable drugs in rats. Int J Pharm 2010;393:244-252.
14. Inapagolla R, Guru BR, Kurtoglu YE, Gao X, Lieh-Lai M, Bassett DJ et al. In vivo efcacy of dendrimer-methylprednisolone conjugate formulation for the treatment of lung infammation. Int J Pharm 2010;399:140-147.
15. Borowska K, Laskowska B, Magon A, Mysliwiec B, Pyda M, Wolowiec S. PAMAM dendrimers as solubilizers and hosts for 8-methoxypsoralene enabling transdermal difusion of the guest. Int J Pharm 2010;398:185-189.
16. Menjoge AR, Rinderknecht AL, Navath RS, Faridnia M, Kim CJ, Romero R et al. Transfer of PAMAM dendrimers across human placenta: prospects of its use as drug carrier during pregnancy. J Control Release 2011;150:326-338.
17. Winnicka K, Bielawski K, Rusak M, Bielawska A. The Effect of generation 2 and 3 poly (amidoamine) dendrimers on viability of human breast cancer cells. J Health Sci 2009;55:169-177.
18. Fischer D, Li Y, Ahlemeyer B, Krieglstein J, Kissel T. In vitro cytotoxicity testing of polycations: infuence of polymer structure on cell viability and hemolysis. Biomaterials 2003;24:1121-1131.
19. Fischer D, Bieber T, Li Y, Elsässer HP, Kissel T. A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: effect of molecular weight on transfection efciency and cytotoxicity. Pharm Res 1999;16:1273-1279.
20. Xu XH, Zhao TQ. Effects of puerarin on D-galactose-induced memory defcits in mice. Acta Pharmacol Sin 2002;23:587-590.
21. Zhu JH, Wang XX, Chen JZ, Shang YP, Zhu JH, Guo XG et al. Effects of puerarin on number and activity of endothelial progenitor cells from peripheral blood. Acta Pharmacol Sin 2004;25:1045-1051.
22. Hsu FL, Liu IM, Kuo DH, Chen WC, Su HC, Cheng JT. Antihyperglycemic effect of puerarin in streptozotocin-induced diabetic rats. J Nat Prod 2003;66:788-792.
23. Luo CF, Yuan M, Chen MS, Liu SM, Zhu L, Huang BY et al. Pharmacokinetics, tissue distribution and relative bioavailability of puerarin solid lipid nanoparticles following oral administration. Int J Pharm 2011;410:138-144.
24. Sui WP, Yin CQ, Chen YJ, Zhang ZG, Kong XZ. Self-assembly of an amphiphilic derivative of chitosan and micellar solubilization of puerarin. Colloids Surf B Biointerfaces 2006;48:13-16.
25. Yu A, Wang H, Wang J, Cao F, Gao Y, Cui J et al. Formulation optimization and bioavailability after oral and nasal administration in rabbits of puerarin-loaded microemulsion. J Pharm Sci 2011;100:933-941.
26. Boisselier E, Ornelas C, Pianet I, Aranzaes JR, Astruc D. Four generations of water-soluble dendrimers with 9 to 243 benzoate tethers: synthesis and dendritic effects on their ion pairing with acetylcholine, benzyltriethylammonium, and dopamine in water. Chemistry 2008;14:5577-5587.
27. Hu J, Cheng Y, Ma Y, Wu Q, Xu T. Host-guest chemistry and physicochemical properties of the dendrimer-mycophenolic acid complex. J Phys Chem B 2009;113:64-74.
28. Cheng Y, Qu H, Ma M, Xu Z, Xu P, Fang Y et al. Polyamidoamine (PAMAM) dendrimers as biocompatible carriers of quinolone antimicrobials: an in vitro study. Eur J Med Chem 2007;42:1032-1038.
29. Devarakonda B, Hill RA, de Villiers MM. The effect of PAMAM dendrimer generation size and surface functional group on the aqueous solubility of nifedipine. Int J Pharm 2004; 284:133-140.
30. Prieto MJ, Schilrref P, Tesoriero M V, Morilla MJ, Romero EL. Brain and muscle of Wistar rats are the main targets of intravenous dendrimeric sulfadiazine. Int J Pharm 2008;360:204-212.
31. Malik N, Wiwattanapatapee R, Klopsch R, Lorenz K, Frey H, Weener JW et al. Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo. J Control Release 2000;65:133-148.
32. Asthana A, Chauhan AS, Diwan P V, Jain NK. Poly(amidoamine) (PAMAM) dendritic nanostructures for controlled site-specifc delivery of acidic anti-infammatory active ingredient. AAPS PharmSciTech 2005;6:E536-E542.
33. Cao F, Guo JX, Ping QN, Liao ZG. Prodrugs of scutellarin: ethyl, benzyl and N, N-diethylglycolamide ester synthesis, physicochemical properties, intestinal metabolism and oral bioavailability in the rats. Eur J Pharm Sci 2006;29:385-393.
34. Xiao YY, Song YM, Chen ZP, Ping QN. The preparation of silybin-phospholipid complex and the study on its pharmacokinetics in rats. Int J Pharm 2006;307:77-82.
35. Xiao YY, Song YM, Chen ZP, Ping QN. Preparation of silymarin proliposome: a new way to increase oral bioavailability of silymarin in beagle dogs. Int J Pharm 2006;319:162-168.
36. Zhou S, Lim LY, Chowbay B. Herbal modulation of P-glycoprotein. Drug Metab Rev 2004;36:57-104.
37. El-Sayed M, Ginski M, Rhodes C, Ghandehari H. Transepithelial transport of poly(amidoamine) dendrimers across Caco-2 cell monolayers. J Control Release 2002;81:355-365.
38. Kolhatkar RB, Kitchens KM, Swaan PW, Ghandehari H. Surface acetylation of polyamidoamine (PAMAM) dendrimers decreases cytotoxicity while maintaining membrane permeability. Bioconjug Chem 2007;18:2054-2060.
39. Cui DM, Xu QW, Gu SX, Shi JL, Che XM. PAMAM-drug complex for delivering anticancer drug across blood-brain barrier in-vitro and in-vivo. Afr J Pharm Pharmaco 2009;3:227-233.